NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.880
+0.020 (1.08%)
At close: Jul 10, 2026, 4:00 PM EDT
1.926
+0.046 (2.43%)
After-hours: Jul 10, 2026, 7:54 PM EDT
NervGen Pharma Employees
NervGen Pharma had 10 employees as of December 31, 2025. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
n/a
Profits / Employee
-$2,997,769
Market Cap
199.66M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 10 | 3 | 42.86% | 9 | 1 |
| Dec 31, 2019 | 7 | - | - | 7 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Humacyte | 184 |
| LENZ Therapeutics | 152 |
| Tonix Pharmaceuticals Holding | 142 |
| Alector | 103 |
| Caribou Biosciences | 97 |
| Immunic | 95 |
| Tenaya Therapeutics | 70 |
NGEN News
- 4 weeks ago - NervGen Pharma initiated with a Buy at TD Cowen - TheFly
- 6 weeks ago - NervGen Pharma files $250M mixed securities shelf - TheFly
- 6 weeks ago - NervGen Pharma Registration statement: Registration filing - Filings
- 6 weeks ago - NervGen Pharma announces biomechanical gait analyses on recovery with NVG-291 - TheFly
- 6 weeks ago - NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study - GlobeNewsWire
- 7 weeks ago - NervGen Pharma 24M share Spot Secondary priced at $2.50 - TheFly
- 7 weeks ago - NervGen Announces Pricing of US$60.0 Million Public Offering of Securities - GlobeNewsWire
- 7 weeks ago - NervGen Pharma secondary being re-offered at $2.50 per share - TheFly